The sale simplifies Surgery Partners' structure and provides significant cash proceeds, likely for debt reduction or ASC reinvestment. Monitor for regulatory approvals and physician partner votes as key catalysts. The reaffirmed guidance suggests the deal's impact is already factored into the outlook, but execution risk remains until close.
Price Chart
Executive Summary
Surgery Partners announced the sale of its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health for total consideration of ~$795M, valuing the combined facilities at ~$1.15B. The deal simplifies the portfolio, provides substantial cash for debt reduction or reinvestment into higher-growth ASCs, and management reaffirmed 2026 revenue guidance of $3.35B-$3.45B with Adjusted EBITDA of at least $530M. The transaction is subject to approvals and expected to close in the coming months, representing a significant strategic shift but with execution risk until binding.
Key Financial Metrics
Key Facts
- Surgery Partners agreed to sell Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health.
- Total consideration is approximately $795 million, valuing the combined facilities at approximately $1.15 billion.
- The company reaffirmed 2026 revenue guidance of $3.35B-$3.45B and Adjusted EBITDA of at least $530M, excluding the transaction's impact.
- The deal is subject to physician partner approvals, HSR waiting period expiration, and other customary closing conditions.
- Expected close is 'in the coming months.'
Financial Impact
Total consideration of ~$795M; combined facility valuation of ~$1.15B; 2026 revenue guidance reaffirmed at $3.35B-$3.45B; Adjusted EBITDA guidance of at least $530M.
Risk Factors
- Failure to obtain physician partner approvals or HSR clearance could delay or terminate the deal.
- The transaction is not yet fully binding and carries execution risk until all conditions are satisfied.
- Proceeds deployment (debt reduction vs. reinvestment) is unspecified and could affect future growth trajectory.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3332858 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | DEFA14A | $23.32 | awaiting T+5 | — | $23.25 (−0.30%) |
Oct 26, 2026 today | SC 13D/A | $19.47 | awaiting T+5 | — | $23.25 (+19.41%) |
Oct 26, 2026 today | DEFA14A | $19.47 | awaiting T+5 | — | $23.25 (+19.41%) |
Oct 26, 2026 today | 8-K | $19.47 | awaiting T+5 | — | $23.25 (+19.41%) |
Oct 13, 2026 13d ago | SC 13G | $14.83 $15.40 | ▲ +3.84% | ▲ +3.39% | $23.25 (+56.78%) |
Sep 17, 2026 5w ago | 8-K | $13.35 $14.20 | ▲ +6.37% | ▲ +5.77% | $23.25 (+74.16%) |
Sep 17, 2026 5w ago | Press Release | $13.35 $14.20 | ▲ +6.37% | ▲ +5.52% | $23.25 (+74.16%) |
Aug 20, 2026 9w ago | Insider Buy | $14.52 $13.69 | ▼ −5.72% | ▼ −6.19% | $23.25 (+60.12%) |
Aug 10, 2026 11w ago | 8-K | $15.95 $14.36 | ▼ −9.97% | ▼ −9.92% | $23.25 (+45.77%) |
Aug 10, 2026 11w ago | Press Release | $15.95 $14.36 | ▼ −9.97% | ▼ −9.92% | $23.25 (+45.77%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers